Kalaris Therapeutics, Inc.
KLRSNasdaqCIK 1754068HealthcareFiscal year ends Dec 31
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1116:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-344532 |
| 2026-08-1108:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343477 |
| 2026-07-2008:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-308382 |
| 2026-07-1707:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-306737 |
| 2026-07-0616:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-296190 |
| 2026-06-0416:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-257388 |
| 2026-05-2219:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001699737-26-000012 |
| 2026-05-1216:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219328 |
| 2026-05-1208:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218240 |
| 2026-04-2416:25 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001193125-26-177362 |
| 2026-04-1016:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-151215 |
| 2026-03-1716:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-110659 |
| 2026-03-1708:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-109437 |
| 2026-03-0907:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097548 |
| 2026-02-1720:14 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001699737-26-000007 |
| 2025-12-2216:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001699737-25-000032 |
| 2025-12-1807:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-323706 |
| 2025-12-1717:19 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-322950 |
| 2025-11-1216:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277464 |
| 2025-11-1208:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-276060 |
| 2025-11-0307:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-261697 |
| 2025-08-1316:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107979 |
| 2025-08-1308:16 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-179466 |
| 2025-08-1308:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-179464 |
| 2025-07-0107:30 ET | DEF 14A | Proxy statementPeriod 2025-08-12 | 0001193125-25-153439 |
| 2025-06-2007:20 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-25-143202 |
| 2025-05-1416:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071339 |
| 2025-05-1408:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-119408 |
| 2025-04-1616:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-082819 |
| 2025-04-0408:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-072869 |
| 2025-03-2519:40 ET | SCHEDULE 13D | Ownership report, active investor | 0001415889-25-008979 |
| 2025-03-1817:04 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-056725 |
| 2025-03-1216:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-052940 |
| 2025-03-0707:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-035143 |
| 2025-01-1516:39 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-007077 |
| 2025-01-1017:00 ET | 8-K | 8.01 Other events | 0001193125-25-004527 |
| 2025-01-1007:42 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-004091 |
| 2024-12-2016:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-283140 |
| 2024-12-0607:23 ET | DEF 14A | Proxy statementPeriod 2025-01-09 | 0001193125-24-271972 |
| 2024-11-1216:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125295 |
| 2024-11-0808:26 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-253747 |
| 2024-08-0909:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094380 |
| 2024-07-0216:15 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-174335 |
| 2024-06-1117:10 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-159226 |
| 2024-06-0716:03 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-157311 |
| 2024-06-0316:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-153013 |
| 2024-05-1316:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058607 |
| 2024-04-2316:05 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001193125-24-106976 |
| 2024-03-1508:43 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-031879 |
| 2024-02-1216:34 ET | 8-K | 3.01 Delisting notice | 0001193125-24-032160 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 17:31 ET. Listed shows no prices and gives no investment advice.